
When healthcare leaders gather to discuss the future of their practices, the conversation frequently turns to expansion. In recent years, an increasing number of primary care practices, behavioral health organizations, specialty clinics, and federally qualified health centers (FQHCs) have begun exploring the possibility of bringing laboratory services in-house.
It is easy to understand the appeal. Healthcare executives constantly strive to improve patient care, shorten diagnostic turnaround times, enhance continuity of care, and deepen patient engagement. At the same time, organizations are looking for sustainable revenue diversification strategies in an increasingly complex reimbursement environment. Adding an in-house laboratory seems like a natural bridge between clinical excellence and business growth.
However, whenever someone asks me whether opening a laboratory is a good idea, my answer is always the same: it depends.
Not every healthcare organization should start a laboratory. In fact, rushing into laboratory ownership without rigorous planning can quickly turn a strategic asset into an administrative and financial liability. Success does not come from enthusiasm alone; it depends on patient volume, payer reimbursement realities, strict compliance requirements, organizational readiness, and long-term strategic alignment.
Over my years in healthcare leadership, operations, and practice management, I have seen organizations thrive by integrating laboratory services—and I have seen others struggle because they skipped fundamental evaluations. Let us walk through what it truly takes to evaluate, structure, and implement laboratory services within an existing healthcare organization.
Section 1: Understanding Laboratory Ownership
When considering a laboratory, the first fundamental decision revolves around ownership structure. How you own and operate your laboratory impacts everything from your liability exposure and governance to your tax strategy and regulatory oversight.
There are several primary ownership models commonly utilized in healthcare:
Direct Ownership by the Existing Entity: The laboratory operates as a department or division within your current legal structure.
Advantages: Maximum administrative simplicity, unified management, and utilization of existing corporate infrastructure.
Disadvantages: Direct exposure of the core practice to laboratory-specific liabilities and regulatory audits.
A Separate Legal Entity: Creating a distinct corporate entity (such as a separate LLC or corporation) specifically for the laboratory.
Advantages: Provides a degree of liability separation, simplifies accounting and financial tracking, and offers greater contracting flexibility if bringing in outside partners.
Disadvantages: Increased administrative overhead, separate corporate governance requirements, and distinct state licensing obligations.
Joint Ventures and Strategic Partnerships: Partnering with external entities, larger health systems, or strategic investors.
Advantages: Shared capital expenditure, access to specialized operational expertise, and pre-established volume channels.
Disadvantages: Shared control, complex profit-distribution rules, and heightened scrutiny under federal fraud and abuse laws.
Physician Ownership Considerations: For physician-owned practices, ownership models must be carefully evaluated against federal and state self-referral prohibitions.
Ultimately, governance, liability exposure, administrative oversight, and strategic control must align with your organization’s long-term goals and risk tolerance. There is no universal template; your structure must fit your specific operational DNA.
Section 2: Organizational Structure Options
Drilling down further into operational mechanics, organizations generally choose between two primary structural pathways when bringing lab services online: operating under the existing Tax Identification Number (TIN) versus establishing a separate legal entity.
Option A: Operating Under the Existing Organization's TIN
Benefits: This is the most straightforward pathway. Credentialing with certain payers can sometimes be streamlined if billed under the established practice TIN, and overhead costs associated with setting up a brand-new corporate entity are eliminated.
Challenges: All financial risks, compliance liabilities, and billing irregularities flow directly into the primary operating entity. If an issue arises in the laboratory, the core medical practice shares immediate exposure.
Option B: Creating a Separate Legal Entity
Benefits: A separate corporate veil provides clear liability separation, isolates financial performance for clean accounting, and gives the organization flexibility in structuring future equity or partnership arrangements.
Challenges: Separate tax filings, independent corporate governance, distinct state licensure, and potentially complex commercial payer credentialing processes from scratch.
When evaluating which structure is preferable, leadership must weigh administrative convenience against risk mitigation. As is true for almost every major operational decision in healthcare, it depends on your practice size, capitalization, risk tolerance, and long-term vision.
Section 3: Certifications and Regulatory Requirements
You cannot simply purchase analyzer equipment, place it in a back room, and begin testing patient samples. The laboratory industry is one of the most heavily regulated sectors in American healthcare, anchored by the Clinical Improvement Amendments of 1988 (CLIA).
Laboratory certification requirements are driven entirely by the type of testing you intend to perform, categorized by complexity:
Waiver Testing: Simple, cleared laboratory tests that have an insignificant risk of erroneous results (e.g., rapid strep tests, urine dipsticks). These require a CLIA Certificate of Waiver.
Provider-Performed Microscopy Procedures (PPMP): Specific moderate-complexity microscopic examinations performed by a physician, mid-level provider, or dentist during a patient visit.
Moderate and High Complexity Testing: Testing that requires sophisticated instrumentation, advanced technical training, and rigorous quality control. These require a CLIA Certificate of Compliance (subject to state or federal surveys) or a Certificate of Accreditation (inspected by an approved private accreditation organization like CAP or COLA).
Understanding these distinctions upfront prevents organizations from investing in sophisticated equipment before realizing their personnel or facility cannot legally support the required complexity level.
Section 4: Understanding CLIA
Because CLIA compliance is non-negotiable, healthcare leaders must understand its foundational purpose. Enacted to ensure quality laboratory testing, CLIA federal oversight applies to all facilities that test human specimens for health assessment, diagnosis, prevention, or treatment.
Building and maintaining a compliant CLIA environment involves several operational pillars:
The Application Process: Submitting Form CMS-116 and navigating state health department interactions.
Inspections and Surveys: Ongoing oversight to verify that quality systems, equipment maintenance logs, and procedure manuals are strictly maintained.
Personnel Requirements: Ensuring that designated roles—Laboratory Director, Technical Supervisor, Testing Personnel—meet strict federal educational and experience qualifications.
Quality Assurance and Proficiency Testing: Enrolling in approved proficiency testing programs where applicable, documenting daily quality controls, and maintaining calibration records.
For healthcare executives, treating CLIA as a one-time setup task is a dangerous mistake. It is an active, ongoing operational commitment that demands continuous administrative vigilance.
Section 5: Other Laws and Regulations That May Apply
Beyond CLIA, operating a laboratory exposes an organization to a complex web of federal and state healthcare laws. While space does not permit an exhaustive legal treatise, leadership must maintain active radar for several critical regulatory domains:
The Stark Law (Physician Self-Referral Law): Prohibits physicians from referring Medicare or Medicaid patients for designated health services (including laboratory services) to entities with which the physician or an immediate family member has a financial relationship, unless a specific statutory or regulatory exception applies.
The Anti-Kickback Statute (AKS): A criminal statute prohibiting the exchange (or offer/receipt) of remuneration of any kind to induce or reward patient referrals or the generation of business payable under federal healthcare programs.
State-Specific Laboratory Regulations: Many states require separate state laboratory licenses, restrict who may direct a lab, or impose specific state-level personnel licensure mandates.
HIPAA Requirements: Ensuring patient health information privacy and security standards extend seamlessly to laboratory data exchange, electronic health record (EHR) interfaces, and specimen transport.
Billing Compliance Rules: Strict adherence to National Coverage Determinations (NCDs), Local Coverage Determinations (LCDs), and proper documentation of medical necessity.
OSHA Requirements: Managing bloodborne pathogens, hazardous chemical safety, and employee protection within the laboratory workspace.
Corporate Practice of Medicine (CPOM): Ensuring corporate entities do not unlawfully exercise professional clinical control where prohibited by state law.
Disclaimer: This overview is for educational and strategic evaluation purposes and does not constitute legal advice. Healthcare organizations must retain qualified healthcare legal counsel and compliance professionals before launching laboratory operations.
Section 6: Can a Practice Refer Its Own Patients?
One of the most common questions practice owners ask is: "Can we perform tests on our own patients in our own lab and bill for them?"
The short answer is: Sometimes, under very specific conditions.
Integrated care models and the In-Office Ancillary Services Exception (IOASE) under the Stark Law often allow physician practices to perform and bill for certain laboratory services rendered to their own patients. The potential benefits are immense: immediate diagnostic results during the patient encounter, streamlined care coordination, and enhanced clinical workflows.
However, navigating this requires walking a regulatory tightrope. Compliance depends entirely on your exact organizational structure, physical location parameters, billing mechanics, payer contract rules, and state-specific restrictions. Assuming that internal referrals are automatically permissible simply because you own the equipment is a recipe for severe regulatory exposure. Proper legal vetting is an absolute prerequisite.
Section 7: Pricing and Billing Strategy
Many organizations view a laboratory as a blank checkbook—assuming that every test performed translates directly into robust net revenue. In reality, laboratory profitability is dictated by sophisticated pricing mechanics and rigorous revenue cycle management (RCM).
Key financial components include:
Fee Schedules and Charge Masters: Establishing defensible pricing structures based on fair market value, regional benchmarks, and payer contracts.
CPT/HCPCS Coding: Ensuring precise code selection that reflects the exact nature and complexity of the diagnostic work performed.
Contracted Payer Reimbursement: Understanding that fee-for-service reimbursement varies wildly across commercial insurance plans, Medicare, and Medicaid.
Patient Collections & Deductibles: Managing high-deductible health plans where patients bear a larger share of diagnostic costs, increasing bad debt risk if upfront estimation fails.
A major mistake organizations make is ignoring volume versus cost thresholds. Performing ten expensive tests a week does not cover the fixed overhead of reagents, calibration, waste management, and specialized labor. Volume and margin must be modeled realistically.
Section 8: Commercial Insurance Challenges
If pricing is the math of a laboratory, commercial insurance relationships are its heartbeat—and often its greatest hurdle. Many practices underestimate how difficult it is to secure profitable payer contracts for in-house laboratory services.
Consider the commercial realities:
Credentialing Hurdles: Getting a laboratory separately credentialed with major commercial insurance carriers can take months, during which time claims may be rejected or treated as out-of-network.
Network Exclusivity and Lab Panels: Many commercial insurers have exclusive or preferred provider arrangements with massive national reference laboratories (e.g., Quest, Labcorp), making it difficult for small in-house labs to secure in-network status.
Prior Authorizations and Denials: Navigating rigorous pre-authorization requirements and medical necessity documentation rules to avoid widespread claims denials.
Before investing substantial capital into lab infrastructure, leadership must analyze payer dynamics in their local market. If local commercial payers refuse to credential your lab or reimburse at rates below your cost of goods sold, the venture will struggle from day one.
Section 9: Return on Investment (ROI)
When evaluating whether to move forward, leaders must look beyond simple top-line revenue and evaluate a holistic Return on Investment (ROI) spanning both financial and administrative dimensions.
A. Financial ROI
Financial analysis must be grounded in hard data, including:
Break-Even Analysis: Calculating exact monthly overhead (rent, equipment leases, licensure, staffing, reagents, waste disposal) against projected reimbursement per test.
Capital vs. Operating Expenses: Factoring in upfront equipment procurement or lease costs, facility build-out expenses, and ongoing maintenance contracts.
Staffing Costs: Accounting for the wages of medical laboratory technicians, technologists, or designated supervisory personnel.
B. Administrative and Strategic ROI
Financial gains tell only part of the story. Laboratories often generate profound operational value through:
Patient Experience & Turnaround Times: Providing point-of-care or rapid in-house results means patients get answers during their visit, eliminating follow-up friction.
Provider Satisfaction: Clinicians make faster, more confident treatment decisions when diagnostic data is instantly available.
Quality Metrics & Clinical Integration: Meeting healthcare quality reporting benchmarks (such as HEDIS measures for chronic disease management) becomes significantly easier when diagnostic tracking is seamless.
It is entirely possible for a laboratory to yield modest direct financial profit while delivering extraordinary value to the broader enterprise through clinical excellence and patient retention.
Section 10: Decision-Making Checklist
Before committing capital, executive leadership should walk through a structured decision framework. Ask your team the following critical questions:
Patient Volume: Do we have sufficient, consistent patient volume to sustain daily testing minimums?
Clinical Scope: Exactly what testing menu are we planning to perform, and why?
Payer Viability: Have we validated commercial insurance and Medicare reimbursement rates for our specific geographic area and tax structure?
Startup & Running Costs: Do we have a complete, transparent accounting of initial capital expenditures and ongoing operational costs?
Compliance Infrastructure: Do we possess the internal compliance resources to maintain rigorous CLIA, OSHA, and billing standards?
Leadership Support: Can our existing management infrastructure support laboratory operations without neglecting core clinical care?
Break-Even Timeline: What is our realistic break-even runway, and do we have the cash reserves to sustain operations during ramp-up?
Clinical Problem Solving: Are we opening a lab to drive revenue, or are we genuinely solving a patient care and workflow bottleneck?
Risk Tolerance: Are we prepared to navigate regulatory audits, payer credentialing delays, and personnel turnover?
Section 11: Recommended Implementation Roadmap
For organizations that decide to proceed after rigorous evaluation, success requires a disciplined, sequential roadmap:
Strategic Evaluation: Define the overarching vision and organizational goals.
Market and Volume Analysis: Quantify actual patient need and test frequency.
Financial Feasibility Study: Model conservative revenue scenarios and break-even timelines.
Legal and Compliance Review: Engage healthcare counsel to review Stark, AKS, and corporate structuring options.
Organizational Structure Selection: Finalize TIN placement or separate legal entity formation.
CLIA Planning & Certification: File Form CMS-116 and prepare for inspections.
Equipment & Vendor Selection: Procure analyzers, software interfaces (LIS/EHR), and consumable supply chains.
Staffing Model Recruitment: Hire and credential qualified laboratory directors and testing personnel.
Payer Strategy Execution: Initiate credentialing and contract negotiations with commercial payers.
Go-Live & Quality Assurance: Implement rigorous quality control logs, proficiency testing, and ongoing performance monitoring.
Conclusion
Laboratory services can be a transformative strategic asset for a forward-thinking healthcare organization. They enhance clinical responsiveness, deepen patient engagement, and diversify operational revenue.
However, not every organization should pursue this opportunity. Success requires meticulous planning, robust operational infrastructure, unwavering compliance discipline, and a clear-eyed view of reimbursement realities. Clinical demand alone is never enough.
As I often remind leadership teams: The organizations that succeed are rarely the ones that move the fastest. They are usually the ones that ask the right questions before making the investment.
Navigating Your Next Steps with Taino Consultants
Evaluating whether to launch, expand, or restructure laboratory services is a complex undertaking that requires objective, experienced guidance. At Taino Consultants, we partner with healthcare executives, primary care practices, FQHCs, and specialty clinics to navigate feasibility evaluations, financial modeling, regulatory preparedness, and operational implementation strategy.
We believe in a grounded, advisory approach—helping you determine whether laboratory services are truly the right fit for your organization. Sometimes, after thorough analysis, the most valuable strategic recommendation we can offer is knowing when not to proceed.
When you are ready to evaluate your organization's readiness, we are here to help you ask the right questions.
About Dr. Jose I. Delgado
Dr. Jose I. Delgado is the founder and CEO of Taino Consultants, a veteran-owned, 8(a) graduate healthcare IT consulting firm based in St. Augustine, Florida. With over 30 years of experience in healthcare compliance and government contracting, Dr. Delgado has helped organizations navigate HIPAA, MACRA/MIPS, and federal IT security requirements.
Need help with healthcare compliance?
Taino Consultants provides HIPAA compliance consulting, MACRA/MIPS compliance support, and healthcare IT modernization services for government and private healthcare organizations.
Schedule a consultationRelated articles

Dental Practices in the U.S.: Protecting Profitability Amid Rising Labor Costs, DSO Competition, and Compliance Scrutiny

Audiology Practices in the U.S.: Navigating Coding Overhauls, OTC Disruption, and Compliance Risks
